当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析 - 资产负债表

科伦药业

(002422)

  

流通市值:469.07亿  总市值:574.02亿
流通股本:13.06亿   总股本:15.98亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金4,092,787,9133,973,908,7155,127,588,8076,108,344,621
应收票据及应收账款4,726,326,2184,795,035,5954,732,202,0404,716,304,952
应收账款4,726,326,2184,795,035,5954,732,202,0404,716,304,952
应收款项融资1,412,947,1281,303,076,4431,671,154,0341,799,908,401
预付款项380,629,051383,493,024664,303,605416,402,286
其他应收款合计186,484,643126,170,377185,399,051181,793,494
其中:应收利息4,838,7464,759,4684,682,2154,602,937
应收股利-10,362,5609,973,76615,205,328
存货3,827,874,3233,800,617,2713,293,343,2023,249,419,928
其他流动资产1,630,824,4791,632,516,4141,435,595,5931,434,768,946
流动资产平衡项目0000
流动资产合计18,489,123,74217,935,981,25019,065,882,89718,930,129,681
非流动资产:
长期股权投资4,283,042,5664,209,814,3704,139,727,7594,062,902,477
其他权益工具投资63,673,18040,737,36140,768,71340,768,713
其他非流动金融资产30,000,00030,000,000--
固定资产11,029,172,12611,175,832,24710,636,441,6299,972,625,596
在建工程1,244,567,0031,204,383,8581,715,774,5472,285,554,162
使用权资产612,343,307631,602,929645,829,315623,962,644
无形资产1,232,886,2631,223,049,2881,220,142,8791,237,373,405
开发支出7,359,2226,363,9868,923,44613,267,035
商誉98,659,99498,659,99498,659,99498,659,994
长期待摊费用74,817,86776,695,96081,525,17585,579,997
递延所得税资产432,937,060423,026,811390,635,478370,505,922
其他非流动资产227,646,551260,111,428348,052,143319,739,924
非流动资产平衡项目0000
非流动资产合计19,337,105,13919,380,278,23219,326,481,07819,110,939,869
资产平衡项目0000
资产总计37,826,228,88137,316,259,48238,392,363,97538,041,069,550
流动负债:
短期借款3,088,477,3212,457,026,5112,592,048,7053,184,206,183
交易性金融负债---256,100
应付票据及应付账款2,439,316,5772,574,351,4662,437,190,5292,607,770,343
其中:应付票据416,836,760205,632,679216,511,903347,862,771
应付账款2,022,479,8172,368,718,7872,220,678,6262,259,907,572
合同负债485,390,867539,513,536237,144,252169,941,735
应付职工薪酬307,452,817621,206,452444,551,052225,093,766
应交税费245,369,531238,590,447284,073,147254,027,307
其他应付款合计1,720,160,2041,815,593,8172,472,366,0652,156,193,151
应付股利-41,900413,663,16235,400
一年内到期的非流动负债790,410,303870,959,558748,863,083417,375,824
其他流动负债15,955,61220,635,981926,483,897618,588,250
流动负债平衡项目0000
流动负债合计9,092,533,2329,137,877,76810,142,720,7309,633,452,659
非流动负债:
长期借款196,000,000342,000,000888,950,0001,364,950,000
租赁负债525,264,310537,460,558558,839,740537,316,013
预计负债3,042,783-5,468,5623,215,650
递延收益299,506,303294,649,250292,042,504301,989,332
递延所得税负债278,955,550266,089,833272,899,667268,670,568
非流动负债平衡项目0000
非流动负债合计1,302,768,9461,440,199,6412,018,200,4732,476,141,563
负债平衡项目0000
负债合计10,395,302,17810,578,077,40912,160,921,20312,109,594,222
所有者权益(或股东权益):
实收资本(或股本)1,598,053,3721,601,497,3731,601,592,1731,601,592,173
资本公积7,713,358,9507,731,605,1398,301,331,6138,275,829,910
减:库存股131,701,776191,834,339192,981,304192,981,304
其他综合收益105,184,636112,993,89584,901,857118,971,287
专项储备2,908,4712,845,4652,761,9712,885,034
盈余公积1,620,121,2581,620,121,2581,419,788,3081,419,788,308
未分配利润12,186,534,16711,602,291,65511,337,635,11311,080,446,841
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计23,094,459,07822,479,520,44622,555,029,73122,306,532,249
少数股东权益4,336,467,6254,258,661,6273,676,413,0413,624,943,079
股东权益平衡项目0000
股东权益合计27,430,926,70326,738,182,07326,231,442,77225,931,475,328
负债和股东权益合计37,826,228,88137,316,259,48238,392,363,97538,041,069,550
公告日期2025-04-302025-04-242024-10-292024-08-29
审计意见(境内)标准无保留意见
TOP↑